Comments
Loading...

Navidea Biopharmaceutical

NAVBOTCEM
Logo brought to you by Benzinga Data
$0.077900
-0.08-98.72%
At close: Sep 20, 12:29 PM EDT
15 minutes delayed

Navidea Biopharmaceutical (OTC:NAVB) Stock, Earnings Estimates, EPS, And Revenue

Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
$0.6K

Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Navidea Biopharmaceutical (NAVB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Sep 20212021-11-10$-0.08$-0.1127.3 %
Jun 20212021-08-11$-0.09$-0.08-12.5 %
Mar 20212021-05-11$-0.12$-0.08-50.0 %
Dec 20202021-03-24$-0.11$-0.128.33 %

Navidea Biopharmaceutical (NAVB) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Dec 20202021-03-24$219.25K$600.00K-63.5 %
Sep 20202020-11-12$268.39K$150.00K78.9 %
Jun 20202020-08-13$271.10K$156.00K73.8 %

FAQ

Q

When is Navidea Biopharmaceutical (OTCEM:NAVB) reporting earnings?

A

Navidea Biopharmaceutical (NAVB) is scheduled to report earnings on November 12, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Navidea Biopharmaceutical (OTCEM:NAVB)?

A

The Actual EPS was $-0.02, which missed the estimate of $0.00.

Q

What were Navidea Biopharmaceutical’s (OTCEM:NAVB) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.